Clinical Trial Update: Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating silodosin for nocturia in men with benign prostatic hyperplasia has completed, reporting on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Nocturia

Drugs mentioned

• Silodosin (Silodosin)

Snippet

Sponsor: JW Pharmaceutical | Conditions: Nocturia, Benign Prostatic Hyperplasia | Phase 4 | Status: COMPLETED